Jørgensen, N.G.; Kaae, J.; Grauslund, J.H.; Met, Ö.; Nielsen, S.L.; Pedersen, A.W.; Svane, I.M.; Ehrnrooth, E.; Andersen, M.H.; Zachariae, C.;
et al. Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study. Cancers 2021, 13, 911.
https://doi.org/10.3390/cancers13040911
AMA Style
Jørgensen NG, Kaae J, Grauslund JH, Met Ö, Nielsen SL, Pedersen AW, Svane IM, Ehrnrooth E, Andersen MH, Zachariae C,
et al. Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study. Cancers. 2021; 13(4):911.
https://doi.org/10.3390/cancers13040911
Chicago/Turabian Style
Jørgensen, Nicolai Grønne, Jeanette Kaae, Jacob Handlos Grauslund, Özcan Met, Signe Ledou Nielsen, Ayako Wakatsuki Pedersen, Inge Marie Svane, Eva Ehrnrooth, Mads Hald Andersen, Claus Zachariae,
and et al. 2021. "Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study" Cancers 13, no. 4: 911.
https://doi.org/10.3390/cancers13040911
APA Style
Jørgensen, N. G., Kaae, J., Grauslund, J. H., Met, Ö., Nielsen, S. L., Pedersen, A. W., Svane, I. M., Ehrnrooth, E., Andersen, M. H., Zachariae, C., & Skov, L.
(2021). Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study. Cancers, 13(4), 911.
https://doi.org/10.3390/cancers13040911